Silence Therapeutics (SLN) Current Deferred Revenue (2019 - 2025)
Silence Therapeutics (SLN) reported Current Deferred Revenue of $168000.0 for Q4 2025, down 45.1% on a YoY basis from $306000.0 in Q4 2024, and down 44.19% sequentially from $301000.0 in Q3 2025.
Silence Therapeutics (SLN) Current Deferred Revenue (2019 - 2025) Analysis & Trends
Silence Therapeutics (SLN) has 7 years of Current Deferred Revenue data on file, last reported at $168000.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Deferred Revenue fell 45.1% year-over-year to $168000.0; the trailing twelve-month figure through Dec 2025 stood at $168000.0 (down 45.1% YoY), and the FY2025 full-year result was $168000.0, down 45.1% from the prior year.
- Current Deferred Revenue slipped to $168000.0 in Q4 2025, from $301000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $10.4 million in Q4 2022 to a low of $168000.0 in Q4 2025.
- A 5-year average of $3.0 million and a median of $424500.0 in 2025 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue surged 81.6% in 2022 and tumbled 95.22% in 2024, its largest moves.
- Tracing SLN's Current Deferred Revenue over 5 years: stood at $5.7 million in 2021, then surged by 81.6% to $10.4 million in 2022, then tumbled by 38.39% to $6.4 million in 2023, then tumbled by 95.22% to $306000.0 in 2024, then sank by 45.1% to $168000.0 in 2025.
- Business Quant data shows SLN's Current Deferred Revenue at $168000.0 in Q4 2025, $301000.0 in Q3 2025, and $457000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 168,000.00 |
| Sep 30, 2025 | 301,000.00 |
| Jun 30, 2025 | 457,000.00 |
| Mar 31, 2025 | 392,000.00 |
| Dec 31, 2024 | 306,000.00 |
| Dec 31, 2023 | 6.41 Mn |
| Dec 31, 2022 | 10.40 Mn |
| Dec 31, 2021 | 5.73 Mn |
| Dec 31, 2020 | 22.50 Mn |
| Dec 31, 2019 | 3.19 Mn |